Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Motor Neuron Disease, Amyotrophic Lateral Sclerosis”

Showing 20 of 0 results

Not applicableWithdrawnNCT00846560
What this trial is testing

Involvement of Lymphocyte Type B in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Rambam Health Care Campus
Large-scale testing (Phase 3)Ended earlyNCT04944784
What this trial is testing

Evaluate the Efficacy and Safety of Reldesemtiv in Patients With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Cytokinetics 489
Not applicableLooking for participantsNCT06810219
What this trial is testing

Augmented Reality BCI Longitudinal Study for Persons With Late Stage ALS

Who this might be right for
ALS (Amyotrophic Lateral Sclerosis)
Cognixion 10
Not applicableUnknownNCT02759913
What this trial is testing

Evaluate the Performance of a Diagnostic Test in ALS

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Iron Horse Diagnostics, Inc. 300
Not applicableUnknownNCT04953624
What this trial is testing

Appetite and Related Factors in Patients With ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Peking University Third Hospital 200
Testing effectiveness (Phase 2)Ended earlyNCT04326283
What this trial is testing

Trial of Safety, Tolerability and Efficacy of Trametinib (SNR1611) in Patients With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Genuv Inc. 23
Early research (Phase 1)Study completedNCT01091142
What this trial is testing

Single-Ascending-Dose Safety/Tolerability of NP001 in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Neuraltus Pharmaceuticals, Inc. 56
Not applicableStudy completedNCT02559869
What this trial is testing

Imaging and BioFluid Biomarkers in Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Massachusetts General Hospital 86
Testing effectiveness (Phase 2)Ended earlyNCT04494256
What this trial is testing

Assess the Safety, Tolerability, and Effect on Disease Progression of BIIB105 in Participants With Amyotrophic Lateral Sclerosis (ALS) and Participants With the ALS Ataxin-2 (ATXN2) Genetic Mutation

Who this might be right for
Amyotrophic Lateral Sclerosis
Biogen 99
Not applicableStudy completedNCT00011154
What this trial is testing

Exogenous Toxicants and Genetic Susceptibility in ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
National Institute of Environmental Health Sciences (NIEHS) 525
Testing effectiveness (Phase 2)UnknownNCT04849065
What this trial is testing

Clinical Trial on the Use of Cell Therapy in the Treatment of Patients With Amyotrophic Lateral Sclerosis

Who this might be right for
ALS (Amyotrophic Lateral Sclerosis)
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia 100
Large-scale testing (Phase 3)Looking for participantsNCT04302870
What this trial is testing

Motor Neurone Disease - Systematic Multi-Arm Adaptive Randomised Trial

Who this might be right for
Motor Neuron Disease, Amyotrophic Lateral Sclerosis
University of Edinburgh 1,150
Large-scale testing (Phase 3)Not Yet RecruitingNCT06391645
What this trial is testing

Nerve Growth Factor Encapsulated With 2-methacryloyloxyethyl Phosphorylcholine Nanocapsules in the Treatment of Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Beijing Tiantan Hospital 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07813858
What this trial is testing

Colchicine Effect on Amyotrophic Lateral Sclerosis Patients

Who this might be right for
Amyotrophic Lateral Sclerosis
Azienda Ospedaliero-Universitaria di Modena 87
Testing effectiveness (Phase 2)Study completedNCT04569435
What this trial is testing

Study of ANX005 in Adults With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Annexon, Inc. 17
Not applicableStudy completedNCT00339976
What this trial is testing

Exposure to Neurotoxins as Risk Factors for Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral SclerosisALS
National Institute of Environmental Health Sciences (NIEHS)
Testing effectiveness (Phase 2)Ended earlyNCT00690118
What this trial is testing

Study of Pioglitazone in Patients With Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
University of Ulm 219
Not applicableUnknownNCT01897818
What this trial is testing

Communication by Brain - Computer Interface in Amyotrophic Lateral Sclerosis:Feasibility Study

Who this might be right for
Amyotrophic Lateral Sclerosis
Centre Hospitalier Universitaire de Nice 20
Testing effectiveness (Phase 2)UnknownNCT04651855
What this trial is testing

The Evaluation of the Effect of Mesenchymal Stem Cells on the Immune System of Patients With ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Polski Bank Komorek Macierzystych JSC (PBKM) 20
Not applicableStudy completedNCT01889043
What this trial is testing

Monitoring of Non-invasive Ventilation During Sleep in ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Universitaire Ziekenhuizen KU Leuven 40
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation